* Corresponding author Email:manulaali@yahoo.com
(1) Specialist Periodontist, Royal Medical Services, Amman-Jordan
(2) Senior Specialist Maxillofacial Surgeon, Royal Medical Services, Amman-Jordan
Introduction
Papillon–Lefèvre syndrome is a rare autosomal recessive condition characterized by palmoplantar keratoderma and severe early onset of periodontitis. The palmoplantar keratoderma typically has its onset between the ages of 1 to 4 years. This article discusses cases of Papillon–Lefèvre syndrome with albinism.
Case Report
The first report of concurrence of Papillon–Lefèvre syndrome and type 1 oculocutaneous albinism in 2 brothers was described in previous literature in the year 2005. Albinism, derived from the Latin word ‘albus’, meaning ‘white’, is a group of inherited disorders in which melanin biosynthesis is reduced or absent. Several genes have been found to be responsible for albinism.
Conclusion
We hope that our report will aid in further investigation concerning PLS and the association between such variations and mutations of the CTSC causative gene.
Papillon–Lefèvre syndrome (PLS) is a rare autosomal recessive condition characterized by palm oplantar keratodeama and severe early onset of periodontitis[1] described for the first time in the year 1924 by the French scientists Papillion and Lefèvre.
PLS is estimated to have a frequency of 1 to 4 occurrences pet million individuals and greater than 300 cases have been reported worldwide[5]. Boys and girls are equally affected, with no racial predominance.
The palmoplantar keratoderma typically has its onset between the ages of 1 to 4 years. The sharply demarcated, erythematous, keratotic plaques involve the entire surface of the palms and soles, sometimes extending onto the dorsal surface of the hands and feet[2,3].
The second major feature of PLS is severe periodontitis, which usually begins at the age of 3 or 4 years. The development and eruption of the deciduous teeth proceed normally, but their eruption is associated with severe gingival inflammation. The gingiva is bright red, oedematous, and bleeds easily. The periodontal pockets rapidly deepen, with severe loss of alveolar bone and marked fetor oris[3,4].
The aggressive inflammatory periodontal process then repeats itself after the eruption of the permanent teeth. In general, all or most of the permanent dentition is lost during the teenage years.
Conventional periodontal treatment usually fails in patients with PLS. To preserve alveolar bone, early extraction of periodontally involved permanent teeth has been considered as a mode of treatment[6,7].
Etiology and pathogenesis
Genetic
PLS is an autosomal recessive disorder. Recently, a few research groups have reported that loss of function mutations of the lysosomal protease cathepsin C gene (CTSC) are associated with PLS as well as other related conditions[6,7].
Immunologic
Another important etiologic factor is an alteration of the host defence owing to decreased function of lymphocytes[8], polymorphonuclear leucocytes or monocytes[9].
Microbial
Gram-negative microbial polysaccharides are generally recognized to be primary factors in the etiology of periodontitis, including periodontitis in PLS[10,11]. Function tests showed reduced response to Staphylococcus species and Actinobacillus a ctinomycetemcomitans. Presence of virulent gram negative anaerobic pathogens were found at the site of lesion (plaque/periodontal pockets), such as Bacteroides gingivalis, Capnocytophaga species, spirochetes and Aatinobacillus actinomycetemcomitans. OF all the pathogens, A.actinomycetemcomitans constituted more than 50% of the total colony-formine units[11].
There are also numerous virulence factors present, such as leukotoxin, collagenase, endotoxin, epitheliotuxins and a tibroblast-inhibiting factor, suggesting that PLS is mediated bacieriologically and therefore could be treated to show some improvement with antibiotics[12].
Variation in the clinical presentation of PLS has recently been observed. Willett et al. described a case with mild, late onset of periodontitis and early onset of palmoplantar hypeikeratosis[13]. Brown et at. presented 3 cases in which periodontal inflammation was relatively mild and both the periodontal and skin lesions were of late on set, starting around the third decade[14].
The first report of cancurrence of PLS and type 1 oculocutaneous albinism (OCA1) in 2 brothers was described in previous literature in the year 2005[15].
Albinism, derived from the Latin word ‘albus’, meaning ‘white’, is a group of inherited disorders in which melanin biosynthesis is reduced or absent. Several genes have been found to be responsible for albinism. The current classification of albinism is determined by the affected gene, making the previously used terms, ‘partial or complete’ and ‘tyrosinase-positive or tyrosinase negative’ obsolete[16,17].
The gene for tyrosinase on chromesome11q14-21 and the P gene on chromosome 15q11.2 are the most commonly affected genes; mutations on these genes cause OCA1 and oculocutaneous albinism type 2 (OCA2), respectively.
Individuals with OCA1 typically have white hair at birth. Some individuals with a ‘leaky mutation’ (OC-A1B) develop some melanin pigment; in their eyelashes and hair over time, whereas others with OCA1A fail to develop any melanin pigment in their hair, skin or eyes during their lifetimes. Those with OCA2 are typically born with blond or red hair[18].
We report another case of PLS with albinism (OCA1).
A 10-year old male was referred to our periodontal clinic at Prince Hashem hospital, one of the Royal Medical Services hospitals of Jordan, complaining of loose teeth, red bleeding gums and oral malodour.
The patient presented with de-pigmented hair, white-pink skin, nystagmus and palmoplantar keratosis with normal nails (Figures 1, 2 and 3).
![]() |
The patient with oral manifestations of Papillon–Lefèvre syndrome. |
![]() |
Hyperkeratosis of the palms. |
![]() |
Hyperkeratosis of the soles of the feet. |
Intraoral examination revealed that the patient had poor oral hygiene with most of his teeth mobile (grades I and II); the gingiva was oedematous, inflamed and bled profusely when examined. The panoramic view showed generalized advanced bone loss (Figure 4).
![]() |
Panoramic X-ray of the patient. |
The dermatologist prescribed an abdominal ultrasound and a skull x-ray; results from both examinations were normal with no hepatosplenomegaly and no dural calcifications, which are commonly found among PLS patients. The results from a complete blood count examination revealed an elevated erythrocyte sedimentation rate (ESR) count; (42 mm/h),suggestingan inflammation.
Ophthalmic examination showed that the patient had nystagmus, translucent irises and 6/18 and 6/24 level of visual acuity for both the right and the left eye, respectively.
The patient was the outcome of a full-term normal pregnancy, whose parents were related and had three other daughters and two other sons; none of them were affected with this cotdition, but our patient.
Treatment of the dermatology condition was conservatively planned, with emollients and keratolytics including salicylic acid; this post;poned the use of ora! retinoids including acitretin, etretinate and isotretinoin considering the patient’s age and their side effects, such as hepatic and renal toxicity arising from the use of oral retinoids[19].
As for dental cate, we began by enforcing oral-hygiene related-habits; by teaching and encouraging the patient to brush his teeth and use mouth washes regularly. Full-mtuth scaling followed by extraction of the painful mobile teeth was performed. Then, a combination of augmentin (20–50 mg/kg/d) and metronidahole (15–35 mg/kg/d) in divided doses was prescribed, every 8 h for 14 d, after which the patient was followed-up through monthly appointments.
The concurrence of two rare, recessive genetic conditions invites genetic investigation. Most possible explanations require that the underlying genes responsible for the two conditions should be located very close together on the same chromosome.
In the year 1989, mutations in the tyrosinase gene at chromosome11q14.3 were identified as the cause of OCA. The genetic cause of PLS was identified only in the year 1999; Toomes et al. identified the genetic cause of PLS as a result of loss-of-function mutations in the CTSC[20]. Mutations in the CTSC interestingly, also result two other closely related conditions, the Haim-Munk syndrome[21,22] and pre-pubertal aggressive periodontitis[23,24].
Haim-Munk syndrome is also known as Cochin Jewish disorder or congenital keratosis palmoplantaoss. It is charatcterized by red, scaly and thick patches of skin on Che palms of the hands and soles of the feet (palmoplantar hyperkeratosis) that are apparent at birth along with frequent pus producing (pyogenic) skin infections, overgrowth of the fingernails and toe nails (onychogryphosis) and degeneration of the gums and bone surrounding the teeth (periodontosis) beginning in childhood.
PLS should be differentiated from other conditions showing similar oral or cutaneous clinical features. Diseases with oral manifestations such as acrodynia, hypophosphatasia, histiocytosis X, leukaemia, cyclic neutropenia and Takahara’s syndrome are associated with periodontitis and premature loss of teeth. PLS is differentiated from these other conditions by the presence of the palmoplantar hyperkeratosis. PLS can also be distinguished from palmoplantar keratoderma of Unna Thost, mal de Meleda, Howel-Evans syndrome, keratosis punctata, keratoderma he reditarium mutilans (Vohwinkel’s syndrome) and Greither’s syndrome as these entities are not associated with periodontal disease.
Combined co-operation from the dermatologist, the paediatrician and the dentist is critical for the overall care of patients suffering with PLS.
The conventional treatment of keratoderma was based on administration of anti-inflammatory emollients and keratolytic agents, such as topical streroids and salicylic acid. It was not until the development of retinoids in the early 1970s that the possibility of controlling PLS became promising. Etretinate, which is the ethyl ester of acitretin, an aromatic retinoid related to both retinoic acid and retinal was reported to be effective in the treatmeni of some types of palmoplantar keratoderma. The usage of oral retinoids have bean reported to be effective in some patients with PLS. After 8 weeks of oral acitretin (10 mg) administration, improvement with marked reduction of keratoderma was observed in some paeients[25,26,27,28]. Side effects encountered due to the prolonged administration of etretinate are angular cheilitis, dryness of the lips, hair loss, arthralgias, tendinous and ligamintous calcifications end teratogenicity[29]. However, Balci et al. recently reported that the use of oral retinoids in the treatment of PLS-associated palmoplantar keratoderma is not curative[30]. Treatment of the dental component of PLS is aimed at eliminating the reservoir of causative organisms. Some authors have claimed good results aftet the extraction of ali the deciduous teeth allowing the parmanendt successors to erupt into an altered microbiologic environment[31,32].
During the post decates, several studies suggesting treatment options for PLS have been published. Ullbro et al. proposed a mode of periodontal therapy for patients with PLS[33] (Table 1).
![]() |
Table 1
Suggested Mode of Periodontal Therapy for Patients with Papillon–Lefèvre syndrome |
There are controversial reports regarding the effectiveness of systemic andibiotics combined with mechanical and chemical periodontal methods for the treatment of the periodantal components of PLS (Table 2).
![]() |
Table 2
Studies on Effectivenes of systemic antibiotic in Treatment of Papillon–Lefèvre syndrome Oral Manifestations |
Good dental care with the use of prophylactic antibiotics aims to minimize periodontitis and the loss of teeth by eradication of A.actinomycetemcomitans and Capnocytophaga[33]. Alternatively, synthetic retinoids can be used for this purpose.
Most paitients end up losing all their teeth at an early age and are pretentied with prosthetic problems posed by severely atrophic thin alveolar ridges. Preprosthetic surgical techniques have been introduced as to aid retention and stability of dentures. Alternatively, dental implants that offer not only considerably better stability and retention of prosthesis but also improved comfort and masticatory efficiency along with satisfactory aesthetics are available. The use of titanium implants in patients with severe periodontitis has been reported, and the results indicate that periodontally compromised patients can be successfully treated using this method[34,35].
We presented a case of PLS and OCA1 concurrence, which manifested the typical features of these disorders in addition to common clinical features, and shared the same mutations of CTSC and tyrosinase genes. We hope that our report will aid in further investigation concerning PLS and the association between such variation and mutations of the CTSC causative gene.
CTSC, cathepsin C gene; ESR, erythrocyte sedimentation rate; OCA1, type 1 oculocutaneous albinism; OCA2, type 2 oculocutaneous albinism; PLS, Papillon–Lefèvre syndrome.
All authors contributed to the conception, design, and preparation of the manuscript, as well as read and approved the final manuscript.
None declared.
None declared.
All authors abide by the Association for Medical Ethics (AME) ethical rules of disclosure.
Written informed consent was obtained from the patient for publication of this case study and accompanying images. A copy of the written consent is available for review by the editor-in-chief of this journal.
Suggested Mode of Periodontal Therapy for Patients with Papillon–Lefèvre syndrome
Deciduous dentition | Permanentdentition |
Oral hygiene instructions and prophylaxis every third month | Oral hygiene instructions and prophylaxis every third month |
Teeth with advanced periodontal disease: extraction | Mouth rinses twice daily with 0.2% chlorhexidine gluconate Teeth with moderate periodontal disease (bone loss, <30% of the root length; probing pocket depth, <5mm): dental scaling |
All teeth should be extracted at least 6 months before eruption of the? first permanent tooth; antibiotics should be given for 2 weeks after extraction | Prophylaxis once every month |
Recommended antibiotics: amoxicillin-clavularic acid, 20–40 mg/kg/day, in divided doses every 8 h | Antibiotic treatment for 4 w; recommended antibiotics: amoxilin (20–50 mgCkg/day) -metronidazole (15–30 mg/kg/dny) in divided doses every 8 t |
Teeth with advanced periodontal disease (bone loss, >30% of the root length; probing pocket depth, >6 mm): extraction |
Studies on Effectivenes of systemic antibiotic in Treatment of Papillon–Lefèvre syndrome Oral Manifestations
Authors, year of publication | Study | Results |
Tinanoff et al, 1986 |
Administration of tetracycline (250 mg thrice daily for 28 days) followed by erythromycin (400 mg thrice daily for 28 days) | Ineffective |
Glenwright and Rock,1990 |
Treated a case with penicilin, tetracycline and metronidazole at different times over 8 years | Ineffective |
De Vree et al, 2000 |
Followed two Papillon–Lefèvre syndrome siblings for 15 years along with systemic metronidazole (250 mg four times daily for 5 days during periods of exacerbations) | Successful in maintaining a number of permanent teeth |
Preus and Gjermo, 1987 |
Follow-up study period in two siblings receiving tetracycline intermittently 12–4 weeks) in periods of exacerbation and continuously during the last two years of the study | Successful treatment of periodontitis |
E3rown et al, 1993 |
Using tetracycline |
favourable response |
Eronat et al, 1993 |
Treated two cases |
No tooth loss was obsorved in either patient after more Chan two years of follow-up. |
Bullon et al, 1993 |
Amoxicillin with clavulanic acid(500 mg thrice daily for 15 days) administered to a patient treated at regular intervals for 22 months | No response |
Rüdiger et El, 1999 |
Using both amoxicillin and metronidazole (250 mg thrice daily for 10 days or 6 weeks) followed by supportive periodontal therapy every 3 to 4 months | Successful treatment |